Home › Compare › UTRS vs DIVO

UTRS vs DIVO: Dividend Comparison 2026

UTRS yields 2000000.00% · DIVO yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UTRS wins by $4.879226400974806e+39M in total portfolio value
10 years
UTRS
UTRS
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full UTRS calculator →
DIVO
DIVO
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full DIVO calculator →

Portfolio growth — UTRS vs DIVO

📍 UTRS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUTRSDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UTRS + DIVO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
UTRS pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UTRS
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, UTRS beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UTRS + DIVO for your $10,000?

UTRS: 50%DIVO: 50%
100% DIVO50/50100% UTRS
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on UTRS right now

UTRS
Analyst Ratings
3
Buy
1
Sell
Consensus: Buy
Price Target
$100.00
+99999900.0% upside vs current
Range: $100.00 — $100.00
Altman Z
-6.3
Piotroski
2/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UTRS buys
0
DIVO buys
0
No recent congressional trades found for UTRS or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUTRSDIVO
Forward yield2000000.00% ✓4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5% ✓
5-year div CAGR0%5% ✓
Portfolio after 10y$4.879226400974806e+39M$28.0K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$899.19
Total dividends collected$4.879195005460081e+39M$6.4K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: UTRS vs DIVO ($10,000, DRIP)

YearUTRS PortfolioUTRS Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,120$420.00+$200.00M → UTRS
2$3,738,731,768,458$3,738,517,757,009.35$12,357$458.31+$3738731.76M → UTRS
3$65,315,062,866,930,490$65,311,062,423,938,240.00$13,721$499.76+$65315062866.92M → UTRS
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$15,227$544.58+$1066400830062625.00M → UTRS
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$16,885$593.02+$16272182796453826560.00M → UTRS
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$18,713$645.34+$2.3205424011366188e+23M → UTRS
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$20,724$701.81+$3.0927990661046884e+27M → UTRS
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$22,938$762.73+$3.8524105697352695e+31M → UTRS
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$25,372$828.41+$4.484688260147987e+35M → UTRS
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$28,047$899.19+$4.879226400974806e+39M → UTRS

UTRS vs DIVO: Complete Analysis 2026

UTRS — Stock

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Full UTRS Calculator →

DIVO — ETF

DIVO is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in DIVO shares.

Full DIVO Calculator →
📬

Get this UTRS vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UTRS vs SCHDUTRS vs JEPIUTRS vs OUTRS vs KOUTRS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.